Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
Its low valuation, with P/E ratio at 8.3 and 7.14 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The stock, which is currently worth 2024 to 0.41 times its sales, is clearly overvalued in comparison with peers.
The company appears to be poorly valued given its net asset value.
This company will be of major interest to investors in search of a high dividend stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the past year, analysts have significantly revised downwards their profit estimates.
Over the past twelve months, analysts' opinions have been revised negatively.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.